Fernando Augusto Lavezzo Dias

Fernando Augusto Lavezzo Dias

Auto-generated profile, based on publicly available information

Fernando Augusto Lavezzo Dias

Graduate Program in Physiology, Federal University of Parana - UFPR, Curitiba, Brazil

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 September 2013 in Cochrane Database of Systematic Reviews
Verified
Journal Article
Closed access
PDF file
ISIvanizia S Silva
Ivanizia S Silva
GFGuilherme Fregonezi
Guilherme Fregonezi
FDFernando A L Dias
Fernando A L Dias
CRCibele T D Ribeiro
Cibele T D Ribeiro
Ricardo GuerraRicardo Guerra
Ricardo Guerra
GFGardenia M H Ferreira
Gardenia M H Ferreira

1 April 2014 in Circulation: Cardiovascular Genetics
Verified
Journal Article
Closed access
PDF file
MAMarco L. Alves
Marco L. Alves
FDFernando A.L. Dias
Fernando A.L. Dias
RGRobert D. Gaffin
Robert D. Gaffin
JSJillian N. Simon
Jillian N. Simon
EMEric M. Montminy
Eric M. Montminy
BWBeata M Wolska
Beata M Wolska
Background—: Hypertrophic cardiomyopathy (HCM) is a common genetic disorder caused mainly by mutations in sarcomeric proteins and is characterized by maladaptive myocardial hypertrophy, diastolic heart failure, increased myofilament Ca 2+ sensitivity, and high susceptibility to sudden death. We tested the following hypothesis: correction of the increased myofilament sensitivity can delay or prevent the development of the HCM phenotype. Methods and Results—: We used an HCM mouse model with an E180G mutation in α-tropomyosin (Tm180) that demonstrates increased myofilament Ca 2+ sensitivity, severe hypertrophy, and diastolic dysfunction. To test our hypothesis, we reduced myofilament Ca 2+ sensitivity in Tm180 mice by generating a double transgenic mouse line. We crossed Tm180 mice with mice expressing a pseudophosphorylated cardiac troponin I (S23D and S24D; TnI-PP). TnI-PP mice demonstrated a reduced myofilament Ca 2+ sensitivity compared with wild-type mice. The development of pathological hypertrophy did not occur in mice expressing both Tm180 and TnI-PP. Left ventricle performance was improved in double transgenic compared with their Tm180 littermates, which express wild-type cardiac troponin I. Hearts of double transgenic mice demonstrated no changes in expression of phospholamban and sarcoplasmic reticulum Ca 2+ ATPase, increased levels of phospholamban and troponin T phosphorylation, and reduced phosphorylation of TnI compared with Tm180 mice. Moreover, expression of TnI-PP in Tm180 hearts inhibited modifications in the activity of extracellular signal-regulated kinase and zinc finger-containing transcription factor GATA in Tm180 hearts. Conclusions—: Our data strongly indicate that reduction of myofilament sensitivity to Ca 2+ and associated correction of abnormal relaxation can delay or prevent development of HCM and should be considered as a therapeutic target for HCM.

1 October 2019 in Sensors and Actuators B: Chemical
Verified
Journal Article
Closed access
PMPriscilla Mengarda
Priscilla Mengarda
FDFernando A.L. Dias
Fernando A.L. Dias
JPJoão V.C. Peixoto
João V.C. Peixoto
RORaul Osiecki
Raul Osiecki
MBMarcio Fernando Bergamini
Marcio Fernando Bergamini
LMLuiz Marcolino-Junior
Luiz Marcolino-Junior

12 October 2017 in PLOS ONE
Verified
Journal Article
Open access
PDF file
COCamila Maciel De Oliveira
Camila Maciel De Oliveira
AUAnderson Zampier Ulbrich
Anderson Zampier Ulbrich
FNFelipe Silva Neves
Felipe Silva Neves
FDFernando Augusto Lavezzo Dias
Fernando Augusto Lavezzo Dias
AHAndréa Roseli Vançan Russo Horimoto
Andréa Roseli Vançan Russo Horimoto
APAlexandre Da Costa Pereira
Alexandre Da Costa Pereira
Recently, some studies have evaluated the role of adiposity measures in the prediction of hypertension risk, but the results are conflicting. Thus, the aim of this study was to compare which of the four indicators of adiposity (waist circumference–WC, body mass index–BMI, body adiposity index–BAI, and visceral adiposity index–VAI) were better associated with hypertension in a Brazilian population. For this study, were selected 1627 individuals (both genders, and aged over 18 years) resident in the municipality of Baependi, a city located in the Southeast of Brazil. WC, BMI, BAI and VAI were determined according to a standard protocol. Hypertension was defined as mean systolic blood pressure ≥ 140 mmHg and/or diastolic blood pressure ≥ 90 mmHg, and/or antihypertensive drug use. The indicators of adiposity WC, BMI, BAI, and VAI were higher in hypertensive when compared to non-hypertensive individuals. In addition, WC and BMI were most strongly associated with hypertension in men and women, respectively. The area under the curve (AUC) of WC was significantly higher than VAI in men. In women, both AUC of BMI and WC showed higher discriminatory power to predict hypertension than BAI and VAI. The indicators of adiposity WC and BMI were better associated with hypertension than BAI and VAI, in both genders, and it could be a useful tools for the screening of hypertensive patients.

1 August 2006 in Journal of Molecular and Cellular Cardiology
Verified
Journal Article
Closed access
FDFernando A.L. Dias
Fernando A.L. Dias
LWLori A. Walker
Lori A. Walker
GAGrace M. Arteaga
Grace M. Arteaga
JWJohn S. Walker
John S. Walker
KVKalpana Vijayan
Kalpana Vijayan
BWBeata M. Wolska
Beata M. Wolska

1 April 2014 in Brazilian Journal of Physical Therapy
Verified
Journal Article
Open access
PDF file
CFCatharinne C. Farias
Catharinne C. Farias
VRVanessa Resqueti
Vanessa Resqueti
FDFernando A. L. Dias
Fernando A. L. Dias
ABAudrey Borghi-Silva
Audrey Borghi-Silva
RARoss Arena
Ross Arena
GFGuilherme Fregonezi
Guilherme Fregonezi
Key words: rehabilitation; chronic obstructive pulmonary disease; exercise; health care costs